Amylyx Pharmaceuticals Inc
NASDAQ:AMLX

Watchlist Manager
Amylyx Pharmaceuticals Inc Logo
Amylyx Pharmaceuticals Inc
NASDAQ:AMLX
Watchlist
Price: 4.05 USD 2.27% Market Closed
Market Cap: 277.6m USD
Have any thoughts about
Amylyx Pharmaceuticals Inc?
Write Note

Wall Street
Price Targets

AMLX Price Targets Summary
Amylyx Pharmaceuticals Inc

Wall Street analysts forecast AMLX stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for AMLX is 7.65 USD with a low forecast of 3.03 USD and a high forecast of 12.6 USD.

Lowest
Price Target
3.03 USD
25% Downside
Average
Price Target
7.65 USD
89% Upside
Highest
Price Target
12.6 USD
211% Upside

AMLX Last Price Targets
Amylyx Pharmaceuticals Inc

The latest public price target was made on Nov 18, 2024 by Joel Beatty from Robert W. Baird , who expects AMLX stock to rise by 172% over the next 12 months. You can read more about this price target by viewing the article on StreetInsider.

Analyst Price Target Date Article
Joel Beatty
Robert W. Baird
11 USD
Upside 172%
1 month ago
Nov 18, 2024
Baird Upgrades Amylyx Pharmaceuticals inc. (AMLX) to Outperform
StreetInsider
Geoff Meacham
Bank of America Securities
10 USD
Upside 147%
1 month ago
Oct 23, 2024
BofA Securities Upgrades Amylyx Pharmaceuticals inc. (AMLX) to Buy
StreetInsider
Marc Goodman
Leerink Partners
4 USD
Downside 1%
2 months ago
Oct 18, 2024
Leerink Partners Reiterates Market Perform Rating on Amylyx Pharmaceuticals inc. (AMLX)
StreetInsider
Andrew Fein
H.C. Wainwright
8 USD
Upside 98%
2 months ago
Oct 18, 2024
H.C. Wainwright Reiterates Buy Rating on Amylyx Pharmaceuticals inc. (AMLX)
StreetInsider
Graig Suvannavejh
Mizuho Securities
3 USD
Downside 26%
7 months ago
May 14, 2024
Amylyx Pharmaceuticals inc. (AMLX) PT Lowered to $3 at Mizuho
StreetInsider
Joel Beatty
Robert W. Baird
3 USD
Downside 26%
8 months ago
Apr 11, 2024
Amylyx Pharmaceuticals inc. (AMLX) PT Lowered to $3 at Baird on latest AMX0035 data
StreetInsider
Neena Bitritto-Garg
Deutsche Bank
4 USD
Downside 1%
8 months ago
Apr 4, 2024
Amylyx Pharmaceuticals inc. (AMLX) PT Lowered to $4 at Deutsche Bank
StreetInsider
Graig Suvannavejh
Mizuho Securities
4 USD
Downside 1%
9 months ago
Mar 17, 2024
Mizuho Downgrades Amylyx Pharmaceuticals inc. (AMLX) to Neutral
StreetInsider
Show More Price Targets
Show Less Price Targets
Joel Beatty
Robert W. Baird
Price Target 11 USD
Upside/Downside 172%
View Source
Geoff Meacham
Bank of America Securities
Price Target 10 USD
Upside/Downside 147%
View Source
Marc Goodman
Leerink Partners
Price Target 4 USD
Upside/Downside 1%
View Source
Andrew Fein
H.C. Wainwright
Price Target 8 USD
Upside/Downside 98%
View Source
Graig Suvannavejh
Mizuho Securities
Price Target 3 USD
Upside/Downside 26%
View Source
Joel Beatty
Robert W. Baird
Price Target 3 USD
Upside/Downside 26%
View Source
Neena Bitritto-Garg
Deutsche Bank
Price Target 4 USD
Upside/Downside 1%
View Source
Graig Suvannavejh
Mizuho Securities
Price Target 4 USD
Upside/Downside 1%
View Source
Show More Price Targets
Show Less Price Targets
Amylyx Pharmaceuticals Inc Competitors:
Price Targets
200670
Humedix Co Ltd
25% Upside
600085
Beijing Tongrentang Co Ltd
20% Upside
000739
Apeloa Pharmaceutical Co Ltd
28% Upside
IPN
Ipsen SA
20% Upside
PHO
Photocure ASA
59% Upside
DMP
Dermapharm Holding SE
28% Upside
DHG
Dhg Pharmaceutical Joint-Stock Co
1% Upside
SNDL
Sundial Growers Inc
70% Upside

Revenue
Forecast

Revenue Estimate
Amylyx Pharmaceuticals Inc

For the last 3 years the compound annual growth rate for Amylyx Pharmaceuticals Inc's revenue is 737%. The projected CAGR for the next 4 years is -70%.

737%
Past Growth
-70%
Estimated Growth
Estimates Accuracy
-2%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Amylyx Pharmaceuticals Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-6%
Average Miss

Net Income
Forecast

Net Income Estimate
Amylyx Pharmaceuticals Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-22%
Average Miss

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is AMLX's stock price target?
Price Target
7.65 USD

According to Wall Street analysts, the average 1-year price target for AMLX is 7.65 USD with a low forecast of 3.03 USD and a high forecast of 12.6 USD.

What is Amylyx Pharmaceuticals Inc's Revenue forecast?
Projected CAGR
-70%

For the last 3 years the compound annual growth rate for Amylyx Pharmaceuticals Inc's revenue is 737%. The projected CAGR for the next 4 years is -70%.

Back to Top